MAPT and Alzheimer disease: However, when using tau368 in a ratio with t-tau, individuals with AD dementia had a significantly lower ratio than CU elderly individuals, with (P < 0.01) or without (P < 0.001) amyloid pathology, as well as compared to those with non-AD cognitive disorders (P < 0.001; Fig 1A).